CombiMatrix Reports 94-Percent Jump in Q3 Revenue, Though Losses Jump 10 Percent | GenomeWeb

NEW YORK, Oct. 21 (GenomeWeb News) - CombiMatrix today reported a 94-percent increase in third-quarter revenues atop a jump in R&D spending and widened net losses.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.